TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20224313

Group type: EXPERIMENTAL
Intervention: Guideline implementation strategies of low intensity (n = 8)
Number of subjects: 2076

Group type: EXPERIMENTAL
Intervention: Guideline implementation strategies of moderate intensity (n = 12)
Number of subjects: 2076

Group type: EXPERIMENTAL
Intervention: Guideline implementation strategies of high intensity (n = 12)
Number of subjects: 2076

Group type: EXPERIMENTAL
Intervention: Heart rate > or =125 per minute
Number of subjects: 2076

Group type: EXPERIMENTAL
Intervention: Respiratory rate > or =30 per minute
Number of subjects: 2076

Group type: EXPERIMENTAL
Intervention: Aspiration pneumonia
Number of subjects: 2076

Group type: EXPERIMENTAL
Intervention: Hematocrit <30%
Number of subjects: 2076
Study: 17412473

Group type: EXPERIMENTAL
Intervention: Flupentixol (4-12 mg/d)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Risperidone (2-6 mg/d)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Flupentixol
Number of subjects: 144

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 144
Study: 15842549

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 12190680

Group type: EXPERIMENTAL
Intervention: Total mesorectal excision (TME)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional surgery (CRAB trial)
Number of subjects: 0
Study: 10503165

Group type: EXPERIMENTAL
Intervention: Tamsulosin (0.2 mg once daily)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Terazosin (2 mg once daily)
Number of subjects: 201
Study: 8084417

Group type: EXPERIMENTAL
Intervention: Glucose drink
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2683541

Group type: EXPERIMENTAL
Intervention: Intrapleural bupivacaine (bolus 20 ml followed by 10 ml/h)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine (bolus 9 ml followed by 5 ml/h)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intrapleural bupivacaine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine
Number of subjects: 20
Study: 1122015

Group type: EXPERIMENTAL
Intervention: Methoxyflurane at 0.2 vol.-%
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Methoxyflurane at 0.5 vol.-%
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 50
Study: 31652109

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI) at 10ºC for 10 minutes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Water immersion at room temperature for 10 minutes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (rest for 10 minutes)
Number of subjects: 30
Study: 30396181

Group type: EXPERIMENTAL
Intervention: Group A (inflation with a pneumatic TP of systolic blood pressure + 100 mm Hg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group B (inflation using the arterial occlusion pressure formula)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tourniquet Time (TT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Optic-Nerve Sheath Diameter (ONSD)
Number of subjects: 60
Study: 28604477

Group type: EXPERIMENTAL
Intervention: FDG PET/ceCT
Number of subjects: 181

Group type: COMPARATOR
Intervention: ceCT64
Number of subjects: 181
Study: 26663024

Group type: EXPERIMENTAL
Intervention: Cortisol geometric means (nmol/l) for women with ≤5.5 hot flashes per day, N = 103
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Cortisol geometric means (nmol/l) for women with >5.5-8.8 hot flashes per day, N = 103
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Cortisol geometric means (nmol/l) for women with >8.8 hot flashes per day, N = 100
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Cortisol geometric means (nmol/l) for all women
Number of subjects: 306

Group type: COMPARATOR
Intervention: Cortisol values by hot flash frequency tertile
Number of subjects: 306
Study: 25037988

Group type: EXPERIMENTAL
Intervention: Interruption group (single aspirin treatment after thienopyridine interruption)
Number of subjects: 1259

Group type: COMPARATOR
Intervention: Continuation group (DAPT continuation for 6-18 months)
Number of subjects: 1259

Group type: COMPARATOR
Intervention: Continuation group
Number of subjects: 1259

Group type: EXPERIMENTAL
Intervention: Interruption group
Number of subjects: 1259
Study: 22952176

Group type: EXPERIMENTAL
Intervention: Meat (30 to 45 g daily)
Number of subjects: 1062

Group type: COMPARATOR
Intervention: Multimicronutrient-fortified cereal (equicaloric to meat)
Number of subjects: 1062
Study: 19949019

Group type: EXPERIMENTAL
Intervention: Vandetanib monotherapy
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Carboplatin and Paclitaxel (CP)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Vandetanib + Carboplatin + Paclitaxel (VCP)
Number of subjects: 123
Study: 18058066

Group type: EXPERIMENTAL
Intervention: Sustained inflation of the intrarectal balloon with 30 and 60 mL air
Number of subjects: 40

Group type: COMPARATOR
Intervention: Rapid inflation/deflation of the intrarectal balloon with 30 and 60 mL air
Number of subjects: 40
Study: 16274382

Group type: EXPERIMENTAL
Intervention: MHI-5
Number of subjects: 1444
Study: 12126683

Group type: EXPERIMENTAL
Intervention: Adjustable semi-rigid extension splint (Richards splint) for the first 48 hours after surgery
Number of subjects: 55

Group type: COMPARATOR
Intervention: Rehabilitation without a splint
Number of subjects: 55
Study: 9863876

Group type: EXPERIMENTAL
Intervention: Simulated patient visits (intervention trial)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Patient exit interviews
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Facility assessments
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Focus group discussions with staff
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Surveillance data
Number of subjects: 49
Study: 8554862

Group type: EXPERIMENTAL
Intervention: Yooralla programme (CE-based programme)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Traditional early childhood services (Control group)
Number of subjects: 34
Study: 1855083

Group type: EXPERIMENTAL
Intervention: High dose Vincristine (4 mg/m2), TBI (1200 cGy), Cyclophosphamide (3600 mg/m2) as standard conditioning regimen before transplant
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Vincristine, Asta‐Z or none purging
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Isolated relapse
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Overall results
Number of subjects: 56
Study: 6340878

Group type: EXPERIMENTAL
Intervention: sulphinpyrazone, 4 x 200 mg daily for 7 days
Number of subjects: 29

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 29
Study: 30986577

Group type: EXPERIMENTAL
Intervention: Supervised physical therapy (PT)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Home exercise (HE)
Number of subjects: 86
Study: 28376891

Group type: EXPERIMENTAL
Intervention: Aseptic technique for line management with single use intravascular catheter
Number of subjects: 249

Group type: COMPARATOR
Intervention: Standard technique for line management
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Aseptic technique for line management
Number of subjects: 249
Study: 25741817

Group type: EXPERIMENTAL
Intervention: Grape seed oil
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Peanut oil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (500 mg OD aspirin for 7 days)
Number of subjects: 30
Study: 26700124

Group type: EXPERIMENTAL
Intervention: Low Molecular Weight Heparin (LMWH) for 24 weeks
Number of subjects: 2202
Study: 23720247

Group type: EXPERIMENTAL
Intervention: Persistent angina
Number of subjects: 16951

Group type: EXPERIMENTAL
Intervention: Uncontrolled blood pressure (≥140 mm Hg)
Number of subjects: 16951
Study: 21841714

Group type: EXPERIMENTAL
Intervention: Solvent-assisted tape removal using water, alcohol, peanut oil, sunflower oil, and Leukotape remover
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dry tape removal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oil (peanut and sunflower)
Number of subjects: 0
Study: 19801284

Group type: EXPERIMENTAL
Intervention: Computer navigation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Manual navigation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Computer navigation and Manual navigation
Number of subjects: 40
Study: 17074943

Group type: EXPERIMENTAL
Intervention: Quetiapine (200-800 mg/day)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Risperidone (2-8 mg/day)
Number of subjects: 289
Study: 14998418

Group type: EXPERIMENTAL
Intervention: Optimization of drug prescribing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Appropriate and rational prescribing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Research evidence on epidemiology of prescribing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Role of the prescriber and multidisciplinary team
Number of subjects: 0
Study: 11708570

Group type: EXPERIMENTAL
Intervention: 5 mg tropisetron
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: 10 mg tropisetron
Number of subjects: 418

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 418
Study: 10968848

Group type: EXPERIMENTAL
Intervention: Sodium phosphate tablets
Number of subjects: 305

Group type: COMPARATOR
Intervention: Colyte
Number of subjects: 305

Group type: COMPARATOR
Intervention: Fleet Phospho-Soda
Number of subjects: 305
Study: 7625996

Group type: EXPERIMENTAL
Intervention: School-home note with response cost
Number of subjects: 5

Group type: COMPARATOR
Intervention: School-home note without response cost
Number of subjects: 5
Study: 2241313

Group type: EXPERIMENTAL
Intervention: imipenem/cilastatin
Number of subjects: 290

Group type: COMPARATOR
Intervention: tobramycin/clindamycin
Number of subjects: 290
Study: 390972

Group type: EXPERIMENTAL
Intervention: Flupenthixol decanoate
Number of subjects: 64

Group type: COMPARATOR
Intervention: Fluphenazine decanoate
Number of subjects: 64
Study: 31215070

Group type: EXPERIMENTAL
Intervention: Water-filled catheters
Number of subjects: 33

Group type: COMPARATOR
Intervention: Air-charged catheters
Number of subjects: 33
Study: 27776221

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) in the first and second trimester
Number of subjects: 1246

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) in the third trimester
Number of subjects: 1246

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) for vaginal delivery
Number of subjects: 1246

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) for Cesarean delivery
Number of subjects: 1246

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) at the 3rd day after vaginal delivery
Number of subjects: 1246

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) at the 10th day after vaginal delivery
Number of subjects: 1246

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) at the 3rd day after Cesarean delivery
Number of subjects: 1246

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) at the 10th day after Cesarean delivery
Number of subjects: 1246

Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT) levels measured by electrochemiluminescence immunoassay (ECLIA) in non-pregnant women
Number of subjects: 1246
Study: 26059521

Group type: EXPERIMENTAL
Intervention: Adalimumab plus methotrexate (MTX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methotrexate (MTX) monotherapy
Number of subjects: 0
Study: 23899468

Group type: EXPERIMENTAL
Intervention: Abacavir/lamivudine (ABC/3TC)
Number of subjects: 385

Group type: COMPARATOR
Intervention: Tenofovir/emtricitabine (TDF/FTC)
Number of subjects: 385
Study: 21972625

Group type: EXPERIMENTAL
Intervention: Deep puncture at Jiaji (EX‐B 2) with round‐sharp needle
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional needling group (acupuncture with filiform needle)
Number of subjects: 150
Study: 19491652

Group type: EXPERIMENTAL
Intervention: Stavudine 30 mg
Number of subjects: 618

Group type: COMPARATOR
Intervention: Stavudine 40 mg
Number of subjects: 618
Study: 16911100

Group type: EXPERIMENTAL
Intervention: Rofecoxib + Paracetamol
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Rofecoxib alone
Number of subjects: 120

Group type: COMPARATOR
Intervention: Paracetamol alone
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 15023488

Group type: EXPERIMENTAL
Intervention: Pindolol plus SSRIs
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo plus SSRIs
Number of subjects: 9
Study: 11209089

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (Cy) plus G-CSF (arm A)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (Cy) plus GM-CSF (arm B)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (Cy) plus GM-CSF followed by G-CSF (arm C)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Good mobilizers (patients who collected a minimum of 2 x 10(6) CD34+ cells/kg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Good mobilizers
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: SDF-1 levels
Number of subjects: 36
Study: 9232040

Group type: EXPERIMENTAL
Intervention: Auralgan otic solution (combination product of antipyrine, benzocaine, and glycerin)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Olive oil placebo
Number of subjects: 54
Study: 8356980

Group type: EXPERIMENTAL
Intervention: Low-dose trimethoprim-sulfamethoxazole (TMP 40 mg, SMX 200 mg) once daily
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 1978615

Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Sufentanil
Number of subjects: 45

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 45

Group type: COMPARATOR
Intervention: Antihypertensive medications
Number of subjects: 45

Group type: COMPARATOR
Intervention: Naloxone
Number of subjects: 45
Study: 332262

Group type: EXPERIMENTAL
Intervention: 2 mg/kg hemisuccinate hydrocortisone (HSHC)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 4 mg/kg hemisuccinate hydrocortisone (HSHC)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 8 mg/kg hemisuccinate hydrocortisone (HSHC)
Number of subjects: 14

Group type: COMPARATOR
Intervention: salbutamol
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study: 31971419

Group type: EXPERIMENTAL
Intervention: Highly Valued Drinking Contexts (HVCs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AUD severity
Number of subjects: 0
Study: 31517322

Group type: EXPERIMENTAL
Intervention: Squamous cell carcinoma (SCC) patients with ERF
Number of subjects: 94

Group type: COMPARATOR
Intervention: Definitive chemoradiation
Number of subjects: 94
Study: 27778328

Group type: EXPERIMENTAL
Intervention: Isotretinoin 10 mg every other day
Number of subjects: 45

Group type: COMPARATOR
Intervention: Antiseborrheic topical treatment
Number of subjects: 45
Study: 25273554

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Indapamide
Number of subjects: 664

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 664
Study: 23705535

Group type: EXPERIMENTAL
Intervention: Full-mouth SRP + SZ (satranidazole)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Full-mouth SRP + placebo
Number of subjects: 66
Study: 21748532

Group type: EXPERIMENTAL
Intervention: Interventional 1 (Int.1) without fundoscopic changes
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Interventional 2 (Int.2) with fundoscopic changes
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (without history of HCQ use)
Number of subjects: 86
Study: 19786440

Group type: EXPERIMENTAL
Intervention: NIDCAP-based care (N = 56)
Number of subjects: 110
Study: 16683674

Group type: EXPERIMENTAL
Intervention: 37% phosphoric acid for 15 seconds
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Non-rinse conditioner (NRC) for 20 seconds
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond (CSEB) for 20 seconds
Number of subjects: 30
Study: 15477550

Group type: EXPERIMENTAL
Intervention: l-methionine 6 g/day in two divided doses
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 11251923

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound for diagnosis of endometrioma
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound for diagnosis of dermoid cysts
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound
Number of subjects: 132
Study: 9230640

Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg/day
Number of subjects: 28
Study: 8501794

Group type: EXPERIMENTAL
Intervention: Orchiectomy and mitomycin C
Number of subjects: 119

Group type: COMPARATOR
Intervention: Orchiectomy alone
Number of subjects: 119
Study: 2940301

Group type: EXPERIMENTAL
Intervention: Therafectin (SM-1213)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31740111

Group type: EXPERIMENTAL
Intervention: Brief computerized intervention targeting perceived burdensomeness
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Brief computerized intervention targeting thwarted belongingness
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Brief computerized intervention targeting anxiety sensitivity
Number of subjects: 250

Group type: COMPARATOR
Intervention: Repeated contact control condition
Number of subjects: 250
Study: 29929813

Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA (IncoA) injection, 80–120 units, customized injection approach
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 27269740

Group type: EXPERIMENTAL
Intervention: Nivolumab followed by ipilimumab
Number of subjects: 140

Group type: COMPARATOR
Intervention: Ipilimumab followed by nivolumab
Number of subjects: 140
Study: 24675386

Group type: EXPERIMENTAL
Intervention: Threat condition (character had a highly contagious flu)
Number of subjects: 96

Group type: COMPARATOR
Intervention: No-Threat condition (character accepted to graduate school)
Number of subjects: 96
Study: 22937959

Group type: EXPERIMENTAL
Intervention: Five-week internet-based guided self-help program followed by face-to-face psychotherapy
Number of subjects: 244

Group type: COMPARATOR
Intervention: Control group followed by face-to-face psychotherapy
Number of subjects: 244
Study: 20691435

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg/d)
Number of subjects: 70
Study: 18173341

Group type: EXPERIMENTAL
Intervention: ALIF without reoperation (Group A)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: arthroplasty without repeated operation (Group C)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: arthroplasty (nonrandomized) without repeated operation (Group E)
Number of subjects: 322

Group type: COMPARATOR
Intervention: ALIF with conversion to 360 degrees fusion (Group B)
Number of subjects: 322

Group type: COMPARATOR
Intervention: arthroplasty with supplemental posterior lumbar fixation (Group D)
Number of subjects: 322

Group type: COMPARATOR
Intervention: arthroplasty (nonrandomized) with supplemental posterior lumbar fixation (Group F)
Number of subjects: 322
Study: 15817001

Group type: EXPERIMENTAL
Intervention: Task-oriented walking intervention
Number of subjects: 91
Study: 12876172

Group type: EXPERIMENTAL
Intervention: HaloLite nebuliser
Number of subjects: 15

Group type: COMPARATOR
Intervention: Pari LC Plus nebuliser
Number of subjects: 15
Study: 10099857

Group type: EXPERIMENTAL
Intervention: Flunarizine 10 mg at bedtime for 1 and 3 months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Bromocriptine (BRC) 2.5 mg
Number of subjects: 10
Study: 8904947

Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 0
Study: 1651201

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg.day‐1)
Number of subjects: 10
Study: 6617932

Group type: EXPERIMENTAL
Intervention: Ambulation during the first stage of labor
Number of subjects: 630

Group type: COMPARATOR
Intervention: Control group (non-ambulant)
Number of subjects: 630
Study: 31686768

Group type: EXPERIMENTAL
Intervention: Prebiotic UG1601
Number of subjects: 0
Study: 29870446

Group type: EXPERIMENTAL
Intervention: Corticosteroid + lidocaine (40 mg triamcinolone acetonide plus 5 mL of 1% lidocaine)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Corticosteroid + lidocaine
Number of subjects: 108

Group type: COMPARATOR
Intervention: Lidocaine alone (6 mL of 1% lidocaine)
Number of subjects: 108
Study: 26135532

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at 40% of maximal inspiratory pressure (MIP) for 6 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group received IMT at 5% of MIP for 6 weeks
Number of subjects: 38
Study: 25323182

Group type: EXPERIMENTAL
Intervention: Amoxicillin + clavulanic acid (Group A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Oxacillin (Group B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: No antibiotics (Group C)
Number of subjects: 80
Study: 23035641

Group type: EXPERIMENTAL
Intervention: 30-minute manualized Swedish massage protocol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 60-minute manualized Swedish massage protocol
Number of subjects: 0
Study: 19777494

Group type: EXPERIMENTAL
Intervention: Treatment under per-protocol analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noncompliance by switching treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noncompliance by subjects not receiving any treatment
Number of subjects: 0
Study: 17335319

Group type: EXPERIMENTAL
Intervention: Aripiprazole (15-30 mg/day)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Perphenazine (8-64 mg/day)
Number of subjects: 300
Study: 15215002

Group type: EXPERIMENTAL
Intervention: Noninvasive positive-pressure ventilation for 2 hours
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard therapy for 2 hours
Number of subjects: 20
Study: 12224581

Group type: EXPERIMENTAL
Intervention: 20 mg/kg praziquantel
Number of subjects: 0

Group type: COMPARATOR
Intervention: 40 mg/kg praziquantel
Number of subjects: 0